oligonucleotide – Patient Worthy

Photo by Robina Weermeijer on Unsplash

RGLS4326 Granted Orphan Drug Designation for Treatment of ADPKD

Post author:Jessica Lynn
Post published:July 30, 2020
Post category:Autosomal Dominant Polycystic Kidney Disease Polycystic Kidney Disease

In a recent press release, biopharmaceutical company Regulus Therapeutics, Inc. announced that their drug candidate, RGLS4326, received Orphan Drug Designation for the treatment of autosomal dominant polycystic kidney disease…

CLICK HERE TO SHARE YOUR STORY!

We believe rare disease patients are people, not a diagnosis. Through education, awareness and some humor, we help patients, caregivers and support persons by providing relevant and often inspirational news and stories.

Our goals are to share stories, cultivate strong community, provide the latest medical findings, connect people and pioneer production of patient worthy information. Help us attain these goals by telling us a little bit about yourself!

Let’s Work Together!

Keep Up to Date

Learn More